Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Beta Bionics (BBNX) Accumulated Depreciation & Amortization (2023 - 2025)

Beta Bionics' Accumulated Depreciation & Amortization history spans 3 years, with the latest figure at $5.8 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 9.56% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $5.8 million, up 9.56%, while the annual FY2025 figure was $5.8 million, 9.56% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $5.8 million at Beta Bionics, down from $6.3 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $6.3 million in Q3 2025 and bottomed at $4.4 million in Q4 2023.
  • The 3-year median for Accumulated Depreciation & Amortization is $5.8 million (2025), against an average of $5.5 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization grew 18.85% in 2024 before it rose 9.56% in 2025.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $4.4 million in 2023, then increased by 18.85% to $5.3 million in 2024, then grew by 9.56% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for BBNX's Accumulated Depreciation & Amortization are $5.8 million (Q4 2025), $6.3 million (Q3 2025), and $5.9 million (Q2 2025).